Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave]R Choussat, G MontalescotArchives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Non-ST acute coronary syndromes]J Ph Collet, R Choussat, G MontalescotArchives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Review and future perspectives on low-molecular-weight heparin]J P Collet, R Choussat, G MontalescotEuropean Heart Journal|August 26, 1998
Fibrinogen as a risk factor for coronary heart diseaseG Montalescot, J P Collet, R Choussat, et al.Annales De Cardiologie Et D'Angeiologie|February 3, 2004
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes]R Choussat, J P Collet, F Beygui, et al.International Journal of Cardiology|September 29, 2001
Enoxaparin in unstable angina patients with renal failureJ P Collet, G Montalescot, R Choussat, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|December 29, 2005
[Antithrombotics in pre-hospital phase of acute coronary syndromes]J P Collet, R Dumaine, P Ecollan, et al.Circulation|February 7, 2001
Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectorisJ P Collet, G Montalescot, L Lison, et al.The American Journal of Cardiology|October 7, 1998
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failureG Montalescot, G Drobinski, P Meurin, et al.Pageof 14